All News
Treatment of MIS-C COVID in Kids
The NEJM has published results of a real-world efficacty trial showing that COVID infected children with the multisystem inflammatory syndrome in children (MIS-C) respond better to initial IVIG plus glucocorticoids (than IVIG alone) which was associated with less subsequent cardiovascular co
Read ArticleTofacitinib Efficacy in COVID-19 Pneumonia
NEJM has published the results of an observational trial wherein tofacitinib given to patients hospitalized with Covid-19 pneumonia, was shown to significantly lower risk of death or respiratory failure.
Read ArticleWhich patients with psoriasis are at risk to develop PsA?
The potential transition from psoriasis (PsO) to psoriatic arthritis (PsA) has not been a strong focus for several years but is gaining momentum.
Read ArticleRheumNow Podcast - Speak Up! (6.18.2021)
Dr. Jack Cush talks on education, engagement and the challenge of speaking up, if not first!
Read ArticleLinks:
Links:
Links:
Links:
Links:
Links:
Links:
Links:
Links:
Links:
Links:
Links:
Links:
Links:
Links:
Links: